Dr. Michael Shafique is a thoracic oncologist at the Moffitt Cancer Center in Tampa, Florida. He specializes in treating patients with lung cancers, malignant pleural mesothelioma, neuroendocrine tumors, Pancoast tumors, and thymomas, as well as gynecologic malignancies. Dr. Shafique is actively involved in recruiting patients into early-phase clinical trials, particularly those that leverage innovative immunotherapy
Dr. Alexander I. Spira is a medical oncologist and Co-Director at Virginia Cancer Specialists, a Fairfax, Virginia multidisciplinary practice of medical oncologists, hematologists, surgeons, palliative care physicians, nurse practitioners, and physician assistants supported by social workers, dietitians, oncology nurses and oncology pharmacists. Board-certified in Medical Oncology and Internal Medicine, Dr. Spira is actively involved in
Dr. Gregory Michael Lubiniecki is a medical oncologist who specializes in treating patients with lung cancer and malignant pleural mesothelioma at Temple Health’s Fox Chase Cancer Center in Philadelphia, Pennsylvania. Though he left full-time practice to accept a role overseeing cancer research at Merck & Company, he believes it is important both personally and professionally
Dr. Antoinette J. Wozniak is a medical oncologist and Chief Scientific Officer of the Lung Cancer Research Foundation. Most recently Professor of Medicine in the division of Hematology and Oncology at the University of Pittsburgh, leader of the Lung Cancer Disease Center, and Associate Director for Clinical Research at UPMC Hillman Cancer Center in Pittsburgh,
Dr. Frank V. Fossella is a thoracic medical oncologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. He has been providing expert patient care to patients diagnosed with malignant mesothelioma and lung cancer for almost 50 years and has distinguished himself through research seeking treatment options that deliver improved patient outcomes.
Dr. Misako Nagasaka is an accomplished thoracic oncologist and clinical researcher whose use of novel drug protocols has made a significant difference for her lung cancer and mesothelioma patients, as well as for those diagnosed with thyroid cancer. She practices at the University of California-Irvine in Orange, California. In addition to patient care, Dr. Nagasaka’s
Dr. John Wrangle is a thoracic medical oncologist who specializes in treating non-small cell and small cell lung cancer as well as other thoracic malignancies at the Medical University of South Carolina (MUSC). He is dedicated to bringing novel combination immunotherapy treatments to patient care and has developed precision medicine protocols designed to create additional
Dr. Young Kwang Chae is a medical oncologist and researcher with Northwestern Medicine in Chicago, Illinois, and an Associate Professor of Medicine in the Hematology Oncology Division of the Feinberg School of Medicine. He specializes in treating patients with malignant mesothelioma, lung cancer, breast cancer, and other cancers with a special focus on the use
Dr. Keisuke Shirai is a Professor of Medicine at the Geisel School of Medicine and a medical oncologist at the Dartmouth Hitchcock Norris Cotton Cancer Center. He is a member of both the lung/thoracic cancer program team and the melanoma/skin cancer program team, and his areas of clinical focus are lung cancer, malignant pleural mesothelioma,
Dr. Jhamil Khatri is a hematologist and oncologist at ChristianaCare in Newark, Delaware and its associated Helen F. Graham Cancer Center. He specializes in treating patients diagnosed with lung cancer and other thoracic malignancies, including malignant pleural mesothelioma. He also cares for patients with blood disorders and other cancer diagnoses. As a member of the